You are here: Industry Insights > tuberculosis

News List

Among Persons With HIV, More Finish Short-Course TB Prophylaxis drugs
August 24, 2021
Tuberculosis preventive treatment completion is higher with three months of rifapentine-isoniazid than six months of isoniazid among patients with HIV receiving antiretroviral therapy, according to a study published online Aug. 24 .
TB Outbreak May Be Linked to Bone Repair Product drugs
June 21, 2021
A tuberculosis outbreak that may be linked to a product used to repair bones is being investigated by U.S. health officials.
Novartis, GSK team up for $3.6m genetic diversity research in Africa pharmaceutical-business-review
January 22, 2021
Swiss pharma giant Novartis and British pharmaceuticals company GSK have teamed up to conduct scientific research linking genetic diversity in Africa and its potential impact on response to drug therapeutics.
Researchers uncover early results about an existing tuberculosis vaccine that has been hypothesized to help against the coronavirus worldpharmanews
September 22, 2020
While scientists race to develop and test a vaccine effective against SARS-CoV-2, the virus that causes COVID-19, recent studies have indicated that countries with widespread BCG vaccination appear to be weathering the pandemic better than their ...
Tuberculosis vaccine may be limiting COVID-19 deaths; dormitory screening urged expresspharma
July 13, 2020
Researchers found that countries with higher rates of Bacille Calmette-Guérin (BCG) vaccinations for tuberculosis had lower peak mortality rates from COVID-19.
Fullerton Health Indonesia Supports National Efforts to Combat Tuberculosis prnasia
March 12, 2020
Fullerton Health Indonesia (FHI) joined President Joko Widodo in the Ministry of Health's launch event "Gerakan Bersama Menuju Eliminasi TBC 2030" (Elimination of Tuberculosis 2030) in Indonesia on 29 January 2020.
Global collaboration formed to develop novel treatment regimens for TB europeanpharmaceuticalreview
March 03, 2020
The Project to Accelerate New Treatments for Tuberculosis (PAN-TB collaboration) was devised to create transformative regimens for TB treatment, irrespective of drug resistance status.
Tuberculosis Rates for U.S. Children Are Low and Declining drugs
August 23, 2019
Overall tuberculosis rates are low among children and adolescents and are declining steadily, according to a study published online in The Lancet Public Health.
TB Cases Drop Among the Young, But Racial Disparities Persist drugs
August 23, 2019
There's good and bad news in a new report on tuberculosis rates among American children and teens: Overall, the number of cases have fallen by nearly half, but they still remain much higher among minorities than whites.
FDA Approves New Treatment for Drug-Resistant TB contractpharma
August 16, 2019
Pretomanid is only the third new anti-TB drug approved by FDA in more than 40 years.

Previous page 1 2 3 4 Next page